Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.38 |
| ▸ | KDM4A | O75164 | 2/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.38 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.38 |
| ▸ | TET3 | O43151 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL13505613 | 1.00 | TP53 (0.69) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 | |
| Lactic Acid SCHEMBL7026852 | 1.00 | TP53 (0.69) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 | |
| Lactic Acid SCHEMBL4263083 | 1.00 | TP53 (0.69) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 | |
| Lactic Acid SCHEMBL419437 | 1.00 | TP53 (0.69) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 | |
| Lactic Acid SCHEMBL424598 | 1.00 | TP53 (0.69) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 | |
| Lactic Acid SCHEMBL4261279 | 1.00 | TP53 (0.69) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 | |
| Lactic Acid SCHEMBL3845012 | 1.00 | TP53 (0.69) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 | |
| Lactic Acid SCHEMBL5269783 | 1.00 | TP53 (0.69) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 | |
| Lactic Acid SCHEMBL2286708 | 1.00 | TP53 (0.69) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 | |
| Lactic Acid SCHEMBL15008846 | 0.97 | TP53 (0.65) | TP53OR51E2CYP1A2SMN1; SMN2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 23964 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119158061-A | Biodegradable tissue repair functional dressing and preparation method thereof | 修原(辽宁)生物有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-118903021-A | Hydromorphone microsphere, preparation method and application thereof | 上海博瑞赛思化学科技有限公司 | 2024-11-08 | — | — | CN | claimed |
| CN-118302193-A | Adjuvant composition and vaccine composition | 株式会社新日本科学 | 2024-07-05 | — | — | CN | claimed |
| WO-2024138921-A1 | NON-HEPATIC TARGETING NUCLEIC ACID NANO-FORMULATION, PREPARATION METHOD THEREFOR, AND USE THEREOF | 华南理工大学 | 2024-07-04 | — | — | WO | claimed |
| WO-2024131925-A1 | MICROSPHERE FILLER AND USE THEREOF | 矩阵(天津)生物科技有限公司 | 2024-06-27 | — | — | WO | claimed |
| US-12018058-B2 | Compositions and methods for diagnosing and/or treating kidney injury | BOSTON MEDICAL CENTER CORPORATION (US) | 2024-06-25 | — | — | US | claimed |
| CN-117815188-A | Drug-loaded microreservoirs with photoactivation effect and related products, uses, methods of preparation and methods of spraying | 深圳信立泰医疗器械股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-115974466-B | Ultra-high-strength concrete and preparation method thereof | 中建三局集团有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-114573706-B | Transport carrier coated with crosslinking agent for targeting chloroplast and application | 中国科学院大连化学物理研究所 | 2024-03-08 | — | — | CN | claimed |
| CN-117660542-A | Preparation method of graphene quantum dot cationic polymer gene vector | 青海民族大学 | 2024-03-08 | — | — | CN | claimed |
| EP-0793965-A2 | Prophylactic/therapeutic composition for secondary cataract | Tano, Yasuo (JP) | 1997-09-10 | — | — | EP | claimed |
| CN-1148956-A | Method of production of sustained-release preparation | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1997-05-07 | — | — | CN | claimed |
| WO-1996025917-A1 | SKIN CARE COMPOSITION | BAUSCH & LOMB INCORPORATED (US) | 1996-08-29 | — | — | WO | claimed |
| EP-0726920-A1 | HIGH MOLECULAR WEIGHT POLYESTERPOLYCARBONATES AND THE USE THEREOF FOR THE PREPARATION OF BIOEROSIBLE MATRICES | ASTA Medica Aktiengesellschaft (DE) | 1996-08-21 | — | — | EP | claimed |
| WO-1995012629-A1 | HIGH MOLECULAR WEIGHT POLYESTERPOLYCARBONATES AND THE USE THEREOF FOR THE PREPARATION OF BIOEROSIBLE MATRICES | MEDIOLANUM FARMACEUTICI S.P.A. (IT) | 1995-05-11 | — | — | WO | claimed |
| EP-0614672-A1 | Biocompatible medical devices | United States Surgical Corporation (US) | 1994-09-14 | — | — | EP | claimed |
| EP-0558697-A1 | LOCALIZED OLIGONUCLEOTIDE THERAPY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-09-08 | — | — | EP | claimed |
| WO-1993008845-A1 | LOCALIZED OLIGONUCLEOTIDE THERAPY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-05-13 | — | — | WO | claimed |
| WO-1993001286-A2 | LOCALIZED OLIGONUCLEOTIDE THERAPY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-01-21 | — | — | WO | claimed |
| US-4917893-A | Prolonged release microcapsules | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-04-17 | — | — | US | claimed |